September 12, 2012
The Osaka District Court will issue a ruling on September 27 on a patent suit filed by Takeda Pharmaceutical demanding that eight companies suspend their manufacturing and marketing of generic versions of Takeda’s type 2 diabetes treatment Actos (pioglitazone), which...read more